EP1787156A1 - Diagnostic automatise de la malaria et d'autres infections - Google Patents
Diagnostic automatise de la malaria et d'autres infectionsInfo
- Publication number
- EP1787156A1 EP1787156A1 EP05762647A EP05762647A EP1787156A1 EP 1787156 A1 EP1787156 A1 EP 1787156A1 EP 05762647 A EP05762647 A EP 05762647A EP 05762647 A EP05762647 A EP 05762647A EP 1787156 A1 EP1787156 A1 EP 1787156A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- automated diagnosis
- images
- diagnosis
- automated
- image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000003745 diagnosis Methods 0.000 title claims abstract description 60
- 201000004792 malaria Diseases 0.000 title claims description 31
- 208000015181 infectious disease Diseases 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 54
- 238000007635 classification algorithm Methods 0.000 claims abstract description 7
- 230000009897 systematic effect Effects 0.000 claims abstract description 4
- 210000003743 erythrocyte Anatomy 0.000 claims description 21
- 201000010099 disease Diseases 0.000 claims description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
- 244000045947 parasite Species 0.000 claims description 18
- 230000000877 morphologic effect Effects 0.000 claims description 13
- 241000606161 Chlamydia Species 0.000 claims description 12
- 238000013528 artificial neural network Methods 0.000 claims description 10
- 238000004422 calculation algorithm Methods 0.000 claims description 10
- 241000894007 species Species 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 9
- 210000004027 cell Anatomy 0.000 claims description 8
- 238000001033 granulometry Methods 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 238000003709 image segmentation Methods 0.000 claims description 4
- 238000010187 selection method Methods 0.000 claims description 4
- 238000001228 spectrum Methods 0.000 claims description 3
- 230000010339 dilation Effects 0.000 claims description 2
- 230000003628 erosive effect Effects 0.000 claims description 2
- 239000013598 vector Substances 0.000 claims description 2
- 238000004364 calculation method Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 238000000386 microscopy Methods 0.000 description 10
- 238000013461 design Methods 0.000 description 6
- 238000002405 diagnostic procedure Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000012774 diagnostic algorithm Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000007781 pre-processing Methods 0.000 description 3
- 230000011218 segmentation Effects 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000012631 diagnostic technique Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000003909 pattern recognition Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- NALREUIWICQLPS-UHFFFAOYSA-N 7-imino-n,n-dimethylphenothiazin-3-amine;hydrochloride Chemical compound [Cl-].C1=C(N)C=C2SC3=CC(=[N+](C)C)C=CC3=NC2=C1 NALREUIWICQLPS-UHFFFAOYSA-N 0.000 description 1
- 208000000230 African Trypanosomiasis Diseases 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000004554 Leishmaniasis Diseases 0.000 description 1
- 241000223105 Trypanosoma brucei Species 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 208000029080 human African trypanosomiasis Diseases 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 201000002612 sleeping sickness Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/0004—Microscopes specially adapted for specific applications
- G02B21/0008—Microscopes having a simple construction, e.g. portable microscopes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1468—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle
- G01N2015/1472—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle with colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1497—Particle shape
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- This invention lies in the field of diagnosis and identification of micro-organisms and other objects.
- the invention has particular application in the field of identification of infections and of pathological conditions, including by the automated visual identification of micro-organisms.
- the invention is applicable over a range of organisms.
- Infectious diseases such as malaria, tuberculosis and sexually transmitted infections (STI's) are a major global health problem, causing millions of deaths annually.
- the economic effect of diseases such as malaria is also significant.
- the control of these diseases requires a rapid and accurate diagnosis that facilitates prompt treatment.
- microscopy Despite advances in diagnostic techniques for malaria and many other diseases, light microscopy remains the most widely and commonly used method. This entails examining thick and thin blood smears for the presence of Plasmodia. It is the most efficient and reliable diagnostic technique, with very high sensitivies and specificities. Microscopy also makes it possible to differentiate between species, quantify parasitaemia and observe asexual stages of the parasites. Low material costs mean that the marginal costs of tests are very low. Microscopy is labour intensive and time consuming and the accuracy of the final diagnosis ultimately depends on the skill and experience of the technician and the time spent studying each slide. Compared with expert microscopy, standard laboratory microscopy has a sensitivity of approximately 90 %, a figure that drops dramatically in the field. Variable smear quality and slide degeneration with time are also problematic.
- Antigen and immunoassay based technologies have also been developed to provide simple 'dip stick' diagnoses for diseases such as malaria and chlamydia. These technologies are extremely portable and require very low levels of training, but have high per test costs and other limitations, such as the inability of malaria testing kits to simultaneously diagnose all species or quantify parasitaemia. In addition, a different test is also required for every disease for which a diagnosis is attempted.
- This invention describes a system to improve upon infectious disease diagnosis by microscopy by removing its most serious limitation, viz. reliance on diagnosis by a human operator. This is achieved by developing a digital image processing system to automate the examination of samples such as (but not limited to) blood, sputum or cervical smears. To be successful, the system must provide at least the same diagnostic information as would normally be provided by a human operator. For example, in the case of malaria, it should give a positive or negative diagnosis of malaria with similar sensitivity and specificity to normal microscopy, differentiate parasites by species and quantify the degree of parasitaemia.
- Chlamydia Chlamydia, gonorrhea, syphilis or tuberculosis, or parasites such as malaria, bilharzias, leishmaniasis and African trypanosomiasis.
- the term "germ” will be used herein to encompass any micro-organism or object that the invention can be applied to.
- a process in accordance with this invention includes the steps of : - capturing images of a germ from suitably prepared sample slides using an automated microscope; and analyzing the images using specially designed algorithms on a computing platform, whereby images are: pre-processed using filters such as median and morphological filters; analysed for relevant information, such as using granulometry to determine object radii; segmented using various novel threshold selection methods; characterized using features generated from first and second order statistical properties of the objects; and classified using these features by means of a suitable classifier such as back propagation feed forward neural networks in a binary tree topology.
- filters such as median and morphological filters
- relevant information such as using granulometry to determine object radii
- segmented using various novel threshold selection methods characterized using features generated from first and second order statistical properties of the objects
- classified using these features by means of a suitable classifier such as back propagation feed forward neural networks in a binary tree topology.
- the system of this invention enables the automatic identification and diagnosis of said diseases and the yielding of other diagnostic information, such as parasite load and species in the case of malaria.
- the capturing of images preferably uses a novel, simple auto configuration of microscope.
- the characterising step may also include novel features that quantify criteria examined by human technicians during manual analysis.
- Apparatus in accordance with this invention incorporates an image acquisition platform that captures microscopic images from a sample slide in an automated, systematic manner and then processes these images on a computing platform using image classification algorithms. Rather than simply being a diagnostic aid to a skilled technician by semi- automating the process and identifying areas of interest, the system is able to replace the technician and completely perform the diagnosis.
- the system also benefits from a novel, simplified configuration that allows for tailored optics, improved ease of use and a more compact physical unit. In addition to the new physical configurations, the system utilizes novel image classification algorithms.
- the ability to integrate a communications system into the invention also makes available a large number of other possibilities such as health reports; remote maintenance and software upgrades; and the remote collection of image samples for scientific purposes. Among other things this will also assist health authorities with, for instance, disease incidence monitoring and optimal allocation of resources.
- the communications module can utilize a range of current or future communications technologies, such as without limitation: GPRS, satellite communications, GSM, Ethernet or WiFi.
- GPRS Global System for Mobile communications
- satellite communications such as Global System for Mobile communications
- GSM Global System for Mobile communications
- Ethernet such as Ethernet
- WiFi Wireless Fidelity
- the input to the system is a suitably stained slide for the targeted disease.
- the slides used are thin blood films, which are routinely stained using the quickdiff protocol, although alternative staining protocols such as the more conventional Giemsa stain are also possible.
- a Gram stain or a commercially available immunoassay such as the MikroTrak Chlamydia trachomatis Direct Specimen Test (Syva Co.) could be used, and for tuberculosis a suitable stain could be a sputum sample stained using, for example, the Ziehl-Neelsen or Auramine stains.
- the input to the system - a suitably stained slide for the target disease - is the same as a technician using a light microscope would use, it can be seamlessly integrated into any existing diagnostic process that is based on light microscopy. This allows a very simple operating process to be used, whereby a sample is prepared as normal for the diagnosis desired, the slide is then inserted into the device and a diagnostic algorithm selected. It is a significant change from current practice that this device performs the diagnosis rather than a technician using a microscope. This makes the invention very flexible (unlike light microscopy), a trained technician is not required) with a wide scope for use (suitable for any diagnosis where the target can be identified on a stained sample fixed to a slide).
- a medical practitioner could review the diagnosis whether remotely (such as over the internet or other communications network) or at the place of use by means of a user interface, such as a PC-based graphical user interface (GUI).
- GUI graphical user interface
- the innovations disclosed enable vastly increased efficiency, greater robustness, ease of use and accuracy when compared to human diagnosis, and are more cost-effective.
- the invention also drastically reduces the manpower requirements required for the diagnostic process, leading to savings and releasing capacity from existing diagnostic operations, as well as making it possible to have accurate, point-of-care diagnosis in many areas that previously have lacked the necessary manpower resources.
- Figure 1 shows a possible configuration of a system embodying the elements of this invention.
- Figure 2 is a flow chart showing the operation of the image acquisition hardware.
- Figure 3 shows a comparison of the image classification algorithms for the general case, malaria and chlamydia.
- Figure 4 shows a design concept that is a possible embodiment of the invention in a robust, portable unit.
- Figure 5 shows the results from some of the steps of applying the malaria algorithm to a sample image.
- FIGURE 1 Microscopic images from a suitably stained slide 7 for a target disease are automatically captured by the image acquisition hardware.
- the hardware consists of a simplified microscope (a tube 5 and lenses 4 with suitable magnification) connected to an image capture device 6; and a stage 1 moveable in the XY-plane to move the microscope field around the slide, and moveable along the Z-axis to allow for autofocus, onto which the slide is loaded.
- Control software controls the movement of the stage and the operation of the image capture device.
- a light source 8 and filter 9 is also provided.
- a possible configuration could be a charge-couple device (CCD) camera connected to a microscope with 1000X magnification, a halogen lamp light source and a stage moveable along the X-, Y- and Z-axes.
- CCD charge-couple device
- the operation of the image acquisition software is such that a series of images 11 is captured from the slide 7 and passed to the relevant diagnostic algorithm 12 until the algorithm indicates that a diagnosis has been made and no more information is required.
- a positive diagnosis could be signaled once several plasmodia have been identified and their species determined, and the level of parasitaemia ascertained.
- a negative diagnosis could be signaled when, for example, ten thousand fields have been examined without finding any parasites.
- chlamydia the presence of as few as ten elementary bodies (EB's) could signal a positive sample, while again a negative sample would require that a large number of fields have been investigated without detecting pathogens.
- the ability to scan and process images sequentially means that the number of fields examined can be increased to as many as is desired, limited only by the area of the sample on the slide. This allows the device to improve upon current diagnostic methods. For example, by scanning a large number of fields in malaria, the sensitivity of the overall diagnosis, which is a function of the sensitivity of the diagnostic algorithm and the number of fields examined, can be made high enough to detect infections even at very low parasite loads. In current manual practice the entire slide is almost never examined.
- the speed of diagnosis is also increased, since the system is not constrained by factors such as operator fatigue. This also improves consistency of performance.
- the images, once captured, are passed to an image classification algorithm shown in the figure that processes them sequentially.
- the general structure of the image classification algorithm is in the form of a pattern recognition and classification system. This consists of a number of stages: image acquisition (implemented by the hardware platform); pre-processing 13 and image analysis 14; image segmentation 15; feature generation 16; and classification 17.
- image acquisition is implemented by the hardware platform
- pre-processing 13 and image analysis 14 image segmentation 15
- feature generation 16 feature generation
- classification 17 classification 17.
- each algorithm is unique and specific to a target disease, but at the same time can all be used on the hardware platform since their input is simply a sequence of images of the sample slide.
- the actual implementation of the image processing algorithms can differ for different diseases.
- the algorithm identifies erythrocytes (red blood cells) and malaria parasites present in the images, and from this information makes a diagnosis as to whether or not malaria is present, and if present, determines the species of the malaria and calculates the level of parasitaemia.
- the first stage 17 of the malaria algorithm involves the use of a median filter to remove noise from the image.
- a morphological area closing filter is also used to generate an image with less detail that is used for certain operations such as erythrocyte segmentation.
- the pre-processing would also involve using suitable median, morphological or other filter implementations to generate an image that can be used for segmentation.
- image analysis is not necessarily required for all diseases (for example chlamydia), but is required for diseases such as malaria since the morphological methods used for image segmentation depend on the size and shape of the objects in the image.
- the size and eccentricity of the erythrocytes is also an important feature for differentiating malaria parasite species.
- Granulometry is used to generate a pattern spectrum that indicates the size distribution of circular objects present in the image, from which the mean erythrocyte radius can be determined.
- the average eccentricity of erythrocytes is determined by the ratio of major to minor axes of cells that are adjudged to be free-standing by virtue of their area.
- An upper limit on the area of an erythrocyte in order for it to be considered free- standing can be calculated from the pattern spectrum, which indicates the mean and standard deviation of the radii of erythrocytes present in an image.
- the granulometry and eccentricity measures are carried out on binary masks.
- a threshold that separates the two principal modes - background and foreground - that are present in the image is used to obtain the mask.
- Figure 5a shows a sample image, with malaria parasites that are to be automatically identified circled.
- the next stage of the algorithm is image segmentation.
- image segmentation For chlamydia, for example, this might only involve a threshold selection method to generate a mask of EB's present, based on the staining of the EB's, and a morphological filteY to ' remove any objects of incorrect size.
- this step is more complicated and requires that potential parasites and erythrocytes are identified and segmented from the image, so that the infected erythrocytes can be extracted.
- Erythrocytes are identified using a threshold that separates the two principal modes - the background and the erythrocytes - that are present in the image histogram (Figure 5b). Morphological filters are then applied to remove small artifacts and smooth the objects present in the mask ( Figure 5c). Parasites are identified using another threshold technique (Figure 5d), derived from the histogram of the green colour component of the image.
- the mask of possible parasites is sued as a marker (figure 5e) to eliminate all erythrocytes from the erythrocyte mask that are not suspected of infection (Figure 5c).
- the infected objects often consist of clumps of overlapping erythrocytes, and it is necessary to separate them.
- a morphological gradient of the greyscale, morphologically filtered green component of the image is constructed by finding the difference between the dilation and erosion of the image. An intersection of the morphological gradient image and the dilated infected cell cluster is used to generate a mask of infected erythrocytes (Figure 5f).
- the next step of the algorithm is to generate features that can be used to correctly classify the objects segmented from the image.
- Our novel approach is to generate first and second order features from characteristics such as texture and colour, and to also generate features that quantify details that a human technician would assess when analyzing a sample. These could include, for example, the relative size of infected cells, the shape and size of possible pathogens and even the spacing between objects that have been identified.
- relevant features include, amongst others, the colour, shape, size and relative position of objects to each other.
- features generated from the infected erythrocytes include but are not limited to first and second order statistical measures that provide quantitative measures of the colour and texture of the objects. Other features are generated that are similar to the specific indicators used by a technician to determine parasite species, such as the size of the parasite, the size of the infected erythrocyte and the position of the parasite in the infected erythrocyte. These features are largely generated from binary masks of the plasmodia and infected erythrocytes, and are novel compared to most other feature generation methods in that rather than making statistical measures of image properties, they quantify measures that are consciously assessed by a human technician when making a diagnosis.
- the final step in the image classification is the classification of the objects based on the feature vectors.
- a single neural network classifier would be a suitable solution.
- the first neural network uses predominantly colour and texture information to separate out false positives (Figure 5h), and the second neural network classifies the plasmodia according to species.
- a number of embodiments of the described invention can be realized. These include, but are not limited to, use as a diagnostic tool, where the device makes an independent diagnosis from the given information, and as a diagnostic aid, where the device makes an assessment that is reviewed by a medical practitioner.
- Figure 4 One possible realization of the device, embodying the invention described, is shown in Figure 4. As shown in this realization, the invention can be integrated into a robust, portable design that allows it to be used in a wide variety of locations. Since the skill level to prepare slides is far lower than that required to analyse slides and make a diagnosis, the diagnostic process using light microscopy can be extended to many locations where it has previously been unfeasible.
- the result from the diagnosis may be conveyed using a user interface.
- a user interface For example, this could take the form of a graphical user interface (GUI) on a liquid crystal display (LCD).
- GUI graphical user interface
- LCD liquid crystal display
- An embodiment of the device could also include a communications module, as indicated in Figure 1 , which allows the invention to form the basis for a wider health monitoring network, for example disease incidence management by health authorities.
- the ability to store results and the development of novel user interfaces can extend an additional embodiment of the device to include patient management. Parasite load can be provided as further diagnostic information and species as for example in the case of malaria.
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Signal Processing (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Dispersion Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
L'invention concerne un procédé et un appareil pour le diagnostic automatisé d'infections, à l'aide d'une plate-forme d'acquisition d'images qui capture des images microscopiques à partir d'une lame porte-échantillon de manière automatisée, systématique et qui traite ensuite lesdites images sur une plate-forme informatique à l'aide d'algorithmes de classification d'images.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200404669 | 2004-06-11 | ||
| PCT/ZA2005/000082 WO2005121863A1 (fr) | 2004-06-11 | 2005-06-10 | Diagnostic automatise de la malaria et d'autres infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1787156A1 true EP1787156A1 (fr) | 2007-05-23 |
Family
ID=34981227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP05762647A Withdrawn EP1787156A1 (fr) | 2004-06-11 | 2005-06-10 | Diagnostic automatise de la malaria et d'autres infections |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP1787156A1 (fr) |
| WO (1) | WO2005121863A1 (fr) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090225319A1 (en) * | 2008-03-04 | 2009-09-10 | California Institute Of Technology | Methods of using optofluidic microscope devices |
| US8416400B2 (en) | 2009-06-03 | 2013-04-09 | California Institute Of Technology | Wavefront imaging sensor |
| US8525091B2 (en) | 2008-05-05 | 2013-09-03 | California Institute Of Technology | Wavefront imaging devices comprising a film with one or more structured two dimensional apertures and their applications in microscopy and photography |
| US8660312B2 (en) | 2009-01-21 | 2014-02-25 | California Institute Of Technology | Quantitative differential interference contrast (DIC) devices for computed depth sectioning |
| US9743020B2 (en) | 2010-03-23 | 2017-08-22 | California Institute Of Technology | Super resolution optofluidic microscopes for 2D and 3D imaging |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010063965A1 (de) | 2010-12-22 | 2012-06-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zur Bestimmung von Objekten einer Farbaufnahme |
| US9522396B2 (en) | 2010-12-29 | 2016-12-20 | S.D. Sight Diagnostics Ltd. | Apparatus and method for automatic detection of pathogens |
| CN104169719B (zh) | 2011-12-29 | 2017-03-08 | 思迪赛特诊断有限公司 | 用于检测生物样品中病原体的方法和系统 |
| WO2013142219A1 (fr) * | 2012-03-20 | 2013-09-26 | The Regents Of The University Of California | Système et procédé pour une télépathologie d'externalisation ouverte |
| EP2999988A4 (fr) | 2013-05-23 | 2017-01-11 | S.D. Sight Diagnostics Ltd. | Procédé et système d'imagerie de prélèvement cellulaire |
| IL227276A0 (en) | 2013-07-01 | 2014-03-06 | Parasight Ltd | A method and system for preparing a monolayer of cells, particularly suitable for diagnosis |
| US10831013B2 (en) | 2013-08-26 | 2020-11-10 | S.D. Sight Diagnostics Ltd. | Digital microscopy systems, methods and computer program products |
| US10482595B2 (en) | 2014-08-27 | 2019-11-19 | S.D. Sight Diagnostics Ltd. | System and method for calculating focus variation for a digital microscope |
| AU2016322966B2 (en) | 2015-09-17 | 2021-10-14 | S.D. Sight Diagnostics Ltd | Methods and apparatus for detecting an entity in a bodily sample |
| US11733150B2 (en) | 2016-03-30 | 2023-08-22 | S.D. Sight Diagnostics Ltd. | Distinguishing between blood sample components |
| US11307196B2 (en) | 2016-05-11 | 2022-04-19 | S.D. Sight Diagnostics Ltd. | Sample carrier for optical measurements |
| EP3455626B1 (fr) | 2016-05-11 | 2025-08-06 | S.D. Sight Diagnostics Ltd. | Exécution des mesures optiques sur un échantillon |
| US10203491B2 (en) | 2016-08-01 | 2019-02-12 | Verily Life Sciences Llc | Pathology data capture |
| US10025902B2 (en) | 2016-08-12 | 2018-07-17 | Verily Life Sciences Llc | Enhanced pathology diagnosis |
| AU2018369859B2 (en) | 2017-11-14 | 2024-01-25 | S.D. Sight Diagnostics Ltd | Sample carrier for optical measurements |
| AU2020372024B2 (en) | 2019-10-22 | 2026-03-12 | S.D. Sight Diagnostics Ltd | Accounting for errors in optical measurements |
| MX2022007127A (es) | 2019-12-12 | 2022-07-11 | S D Sight Diagnostics Ltd | Generacion artificial de una imagen de frotis sanguineo en color. |
| AU2020400400B2 (en) | 2019-12-12 | 2026-03-19 | S.D. Sight Diagnostics Ltd | Detecting platelets in a blood sample |
| BR112022011312A2 (pt) | 2019-12-12 | 2022-08-23 | S D Sight Diagnostics Ltd | Análise de um analito disposto dentro de um meio |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4700298A (en) * | 1984-09-14 | 1987-10-13 | Branko Palcic | Dynamic microscope image processing scanner |
| US5134662A (en) * | 1985-11-04 | 1992-07-28 | Cell Analysis Systems, Inc. | Dual color camera microscope and methodology for cell staining and analysis |
| EP0293083A3 (fr) * | 1987-04-30 | 1990-07-18 | Corabi International Telemetrics, Inc. | Système de diagnostic à télétransmission |
| JPH03291567A (ja) * | 1990-04-10 | 1991-12-20 | Olympus Optical Co Ltd | ウイルス感染検査装置およびウイルス感染検査方法 |
| US6005964A (en) * | 1996-01-24 | 1999-12-21 | The Board Of Trustees Of The University Of Illinois | Automatic machine vision microscope slide inspection system and method |
| EP2299307A3 (fr) * | 2000-11-03 | 2011-05-04 | Cytyc Corporation | Méthode d'imagerie cytologique |
| AU2003253614A1 (en) * | 2002-05-30 | 2003-12-19 | The Johns Hopkins University | Techniques for automated diagnosis of cell-borne anomalies with a digital optical microscope |
-
2005
- 2005-06-10 EP EP05762647A patent/EP1787156A1/fr not_active Withdrawn
- 2005-06-10 WO PCT/ZA2005/000082 patent/WO2005121863A1/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2005121863A1 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090225319A1 (en) * | 2008-03-04 | 2009-09-10 | California Institute Of Technology | Methods of using optofluidic microscope devices |
| US8525091B2 (en) | 2008-05-05 | 2013-09-03 | California Institute Of Technology | Wavefront imaging devices comprising a film with one or more structured two dimensional apertures and their applications in microscopy and photography |
| US8660312B2 (en) | 2009-01-21 | 2014-02-25 | California Institute Of Technology | Quantitative differential interference contrast (DIC) devices for computed depth sectioning |
| US8416400B2 (en) | 2009-06-03 | 2013-04-09 | California Institute Of Technology | Wavefront imaging sensor |
| US9743020B2 (en) | 2010-03-23 | 2017-08-22 | California Institute Of Technology | Super resolution optofluidic microscopes for 2D and 3D imaging |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005121863A1 (fr) | 2005-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1787156A1 (fr) | Diagnostic automatise de la malaria et d'autres infections | |
| US10677711B2 (en) | Method and apparatus for automated whole blood sample analyses from microscopy images | |
| EP2936116B1 (fr) | Système et procédé pour la classification de particules dans un échantillon de fluide | |
| EP3859425B1 (fr) | Méthodes et appareil de détection d'entité dans un échantillon corporel | |
| US5933519A (en) | Cytological slide scoring apparatus | |
| US10083340B2 (en) | Automated cell segmentation quality control | |
| JP3050406B2 (ja) | 正常な生物医学検体を確認する方法 | |
| CN110473167B (zh) | 一种基于深度学习的尿沉渣图像识别系统及方法 | |
| JP2007133859A (ja) | 生体組織の試料および体液の試料の自動顕微鏡支援検査方法 | |
| JP4864709B2 (ja) | 分散プロット分布を用いてスライドの染色品質を決定するシステム | |
| KR20010017092A (ko) | 혈구세포의 형태 자동 분석 및 카운트 방법 | |
| KR101106386B1 (ko) | 산점도 분포를 사용한 슬라이드를 분류하기 위한 시스템 | |
| Serrão et al. | Automatic bright-field smear microscopy for diagnosis of pulmonary tuberculosis | |
| US20190362491A1 (en) | Computer-implemented apparatus and method for performing a genetic toxicity assay | |
| EP4137795A1 (fr) | Procédé d'analyse d'image de fluorescence, analyseur d'image de fluorescence, programme d'analyse d'image de fluorescence | |
| US7257243B2 (en) | Method for analyzing a biological sample | |
| JP7793293B2 (ja) | 画像処理装置、画像処理装置の制御方法およびプログラム | |
| EP3991088B1 (fr) | Contrôle de qualité par balayage/pré-balayage de diapositives | |
| JP2010151523A (ja) | 粒子画像解析方法および装置 | |
| JPH07181123A (ja) | 粒子画像解析装置 | |
| Samuel et al. | Design to automate the detection and counting of Tuberculosis (TB) bacilli | |
| EP4605726A1 (fr) | Analyse visuelle de fragmentation d'adn de sperme | |
| KR20230125999A (ko) | 인공지능을 이용한 면역형광검사 결과 판독 장치 및 그를 이용한 판독방법 | |
| Al-Atabi et al. | Imaging Analysis Systems for Cell Classification, Fluorescence Microscopy Pictures, Medical Illness Diagnosis, and Environmental Monitoring Based on Cytometric Characteristics of Fluorescently Labelled Nuclei | |
| WO2022129867A1 (fr) | Microscopie automatisée |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20070109 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20081231 |